{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:35:09Z","timestamp":1770982509174,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"M\u00e9decins du Monde France"}],"content-domain":{"domain":["ijdp.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.drugpo.2014.01.007","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T09:30:41Z","timestamp":1390469441000},"page":"871-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Hepatitis C among people who inject drugs in Tbilisi, Georgia: An urgent need for prevention and treatment"],"prefix":"10.1016","volume":"25","author":[{"given":"Julie","family":"Bouscaillou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Champagnat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1108-058X","authenticated-orcid":false,"given":"Niklas","family":"Luhmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Avril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Inaridze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Miollany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koka","family":"Labartkava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7498-2380","authenticated-orcid":false,"given":"Irma","family":"Kirtadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maia","family":"Butsashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kamkamidze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Pataut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"October (5)","key":"10.1016\/j.drugpo.2014.01.007_bib0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugpo.2007.04.004","article-title":"Global estimates of prevalence of HCV infection among injecting drug users","volume":"18","author":"Aceijas","year":"2007","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0010","series-title":"The alcohol use disorders identification test: Guidelines for use in primary care","author":"Babor","year":"2001"},{"issue":"September (9)","key":"10.1016\/j.drugpo.2014.01.007_bib0015","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/jmv.22154","article-title":"Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users","volume":"83","author":"Ciccozzi","year":"2011","journal-title":"Journal of Medical Virology"},{"issue":"August (8)","key":"10.1016\/j.drugpo.2014.01.007_bib0020","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2893.2009.01210.x","article-title":"Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection","volume":"17","author":"Cross","year":"2010","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0025","series-title":"Behavioral surveillance Survey on injecting drug users in five cities of Georgia","author":"Curatio International Foundation","year":"2012"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0030","series-title":"Characteristics, high-risk behaviors and knowledge of STI\/HIV\/AIDS, and prevalence of HIV, syphilis and hepatitis among injecting drug users in Batumi, Georgia: 2002\u20132006","author":"Dershem","year":"2007"},{"issue":"February (2)","key":"10.1016\/j.drugpo.2014.01.007_bib0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2893.2008.01050.x","article-title":"FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: A prospective study","volume":"16","author":"Foucher","year":"2009","journal-title":"Journal of Viral Hepatitis"},{"issue":"January\u2013February (1)","key":"10.1016\/j.drugpo.2014.01.007_bib0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/ADM.0b013e318279756f","article-title":"Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users","volume":"7","author":"Gigi","year":"2013","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0045","series-title":"The negative impact of the war on drugs on public health: The hidden hepatitis c epidemic","author":"Global Commission on Drug Policy","year":"2013"},{"issue":"July (1)","key":"10.1016\/j.drugpo.2014.01.007_bib0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"May (2)","key":"10.1016\/j.drugpo.2014.01.007_bib0055","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2307\/3096941","article-title":"Respondent driven sampling, a new approach to the study of hidden population","volume":"44","author":"Heckathorn","year":"1997","journal-title":"Social Problems"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0060","series-title":"Drug situation in Georgia","author":"Javakhishvili","year":"2010"},{"issue":"2","key":"10.1016\/j.drugpo.2014.01.007_bib0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4256\/mio.2010.0017","article-title":"Sampling hard-to-reach populations with respondent driven sampling","volume":"5","author":"Johnston","year":"2010","journal-title":"Methodological Innovations Online"},{"issue":"December (177)","key":"10.1016\/j.drugpo.2014.01.007_bib0070","first-page":"51","article-title":"Prevailing HCV genotypes and subtypes among HIV infected patients in Georgia","author":"Karchava","year":"2009","journal-title":"Georgian Medical News"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0075","article-title":"Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: A longitudinal long-term cohort study","author":"Kielland","year":"2013","journal-title":"Journal of Hepatology"},{"issue":"October (10)","key":"10.1016\/j.drugpo.2014.01.007_bib0080","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/jmv.21850","article-title":"Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France","volume":"82","author":"Larsen","year":"2010","journal-title":"Journal of Medical Virology"},{"issue":"May (5)","key":"10.1016\/j.drugpo.2014.01.007_bib0085","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1360-0443.2010.03246.x","article-title":"Outreach screening of drug users for cirrhosis with transient elastography","volume":"106","author":"Moessner","year":"2011","journal-title":"Addiction"},{"issue":"April (4)","key":"10.1016\/j.drugpo.2014.01.007_bib0090","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0095","series-title":"Hepatitis C treatment: Price, profits, and barriers to access","author":"Momenghailibaf","year":"2013"},{"issue":"August (9791)","key":"10.1016\/j.drugpo.2014.01.007_bib0100","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"Journal of Hepatology"},{"issue":"March (9055)","key":"10.1016\/j.drugpo.2014.01.007_bib0110","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"issue":"December (3)","key":"10.1016\/j.drugpo.2014.01.007_bib0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1017\/S0950268802007902","article-title":"Monitoring hepatitis C virus infection among injecting drug users in the European Union: A review of the literature","volume":"129","author":"Roy","year":"2002","journal-title":"Epidemiology and Infection"},{"issue":"December (165)","key":"10.1016\/j.drugpo.2014.01.007_bib0120","first-page":"71","article-title":"Prevalence of HCV and genotypes distribution in general population of Georgia","author":"Sharvadze","year":"2008","journal-title":"Georgian Medical News"},{"issue":"December (2)","key":"10.1016\/j.drugpo.2014.01.007_bib0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5009\/gnl.2007.1.2.145","article-title":"Simple tests to predict hepatic fibrosis in nonalcoholic chronic liver diseases","volume":"1","author":"Shin","year":"2007","journal-title":"Gut Liver"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0130","series-title":"Estimating the prevalence of injection drug use in five cities of Georgia","author":"Sirbiladze","year":"2009"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0135","series-title":"RDSAT 7.1 user manual","author":"Spiller","year":"2012"},{"issue":"March (2)","key":"10.1016\/j.drugpo.2014.01.007_bib0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11524-006-9032-y","article-title":"Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: A population-based survey of the adult population of Tbilisi, Republic of Georgia","volume":"83","author":"Stvilia","year":"2006","journal-title":"Journal of Urban Health"},{"issue":"January (1)","key":"10.1016\/j.drugpo.2014.01.007_bib0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drugalcdep.2004.07.002","article-title":"The impact of injecting drug use status on hepatitis C-related referral and treatment","volume":"77","author":"Stoov\u00e9","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"November (165)","key":"10.1016\/j.drugpo.2014.01.007_bib0150","first-page":"38","article-title":"Assessment of liver fibrosis and cirrhosis by transient elastography among patients with chronic HBV and HCV infection in Georgia","volume":"12","author":"Tsertsvadze","year":"2008","journal-title":"Georgian Medical News"},{"issue":"November (11)","key":"10.1016\/j.drugpo.2014.01.007_bib0155","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: Pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0160","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0165","series-title":"Epidemiological fact sheet on HIV and AIDS, Georgia, update","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0170","series-title":"Viral hepatitis resolution","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.drugpo.2014.01.007_bib0175","series-title":"Georgia statistics summary","author":"World Health Organization","year":"2013"},{"issue":"February (2)","key":"10.1016\/j.drugpo.2014.01.007_bib0180","first-page":"103","article-title":"Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease","volume":"11","author":"Yilmaz","year":"2011","journal-title":"Hepatitis Monthly"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395914000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395914000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T14:22:50Z","timestamp":1716474170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395914000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0955395914000103"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2014.01.007","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C among people who inject drugs in Tbilisi, Georgia: An urgent need for prevention and treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2014.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}